Timeline of privileges regarding the commercialization and use of knowledge. Part 1: before 1980
Draft
This is work in progress, and is part of a larger project on timelines. This particular timeline is unfinished, and may contain errors.
Search Results for: ustr
US Statement to 48th WIPO General Assemblies on IGC on genetic resources, traditional knowledge and folklore
On Friday, 24 September 2010, the United States delivered the following intervention on agenda item 28(i) on the Information Reports on the Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore.
USPTO to offer new incentives to license patents for humanitarian uses, based upon FDA priority review voucher
The USPTO has a federal register notice out asking for public comment on a welcome new initiative, modeled after the FDA priority review voucher, to create incentives to license patents for humanitarian uses. The initiative is set out here: http://edocket.access.gpo.gov/2010/pdf/2010-23395.pdf.
Timelines
New: Hepatitis Timeline: http://goo.gl/83sp9J
New: Fabry TImeline:
High Level Timelines of privileges regarding the commercialization and use of knowledge
- Timeline of privileges regarding the commercialization and use of knowledge: Part 1: before 1980
Timeline of privileges regarding the commercialization and use of knowledge. Part 3: 2000 and after
Draft
This is work in progress, and is part of a larger project on timelines. This particular timeline is unfinished, and may contain errors.
Timeline of privileged regarding the commercialization and use of knowledge
Your tax dollars at work. Obama administration funding of pro-right holder NGO work on IPR protection, fy 2009
USPTO’s $4 million of Congressionally Mandated Spending on intellectual property initiatives, for fy 2009
This is the USPTO list of grants for fy 2009. The $4 million in grants were used to influence global norms on IPR policy.
A new round of grants will go out soon for fy 2010, involving another $4 million of Congressionally Mandated Spending on Intellectual Property Initiatives (IPI).
Part 2: Notes on the August 25, 2010 version of the ACTA consolidated text
Introduction
Part 1 of our notes on the August 25, 2010 version of the ACTA consolidated text, covering pages 1-9 of the text, are available here. These notes cover the remainder of August 25, 2010 ACTA text, from pages 10 to 29.
Part 1: Notes on the August 25, 2010 version of the ACTA consolidated text
KEI has obtained a copy of the August 25, 2010 version of the ACTA consolidated negotiating text. This is Part 1 of our initial notes on the document.
(Part 2 is available here.)
(revised September 9, 2010)
Preamble
The preamble in the August, 25, 2010 text includes 10 paragraphs, of which only 3 do not have brackets.
European Commission October 5, 1998 note memorandum on the WHO Revised Drug Strategy negotiation
European Commission (DG 1) note on the WHO’s Revised Drug Stategy
EUROPEAN COMMISSION
DIRECTORATE GENERAL 1
EXTERNAL RELATIONS: COMMERCIAL POLICY AND RELATIONS WITH NORTH AMERICA. THE
FAR EAST, AUSTRALIA AND NEW ZEALAND
Directorate D -Sectoral trade questions, market access
New technologies, Intellectual property, public procurement
Brussels, 5 October 1998
1/D/3/BW D (98)
WHA 52.19, the Revised Drug Strategy
A pdf copy of the resolution is attached to this page.
THE FIFTY-SECOND WORLD HEALTH ASSEMBLY
WHA52.19
Agenda Item 13
May 24, 1999
Revised Drug Strategy
The Fifty-second World Health Assembly,
Recalling resolution WHA39.27, WHA41.16, WHA43.20, WHA45.27, WHA47.12, WHA47.13, WHA47.16, WHA47.17, and WHA49.14;
Having considered the report of the Director-General on the revised drug strategy[1];